Background. Occult infection with hepatitis B virus (HBV) is a type of chronic HBV infection that is characterized by the absence of a detectable hepatitis B surface antigen in the blood and by very low levels of HBV DNA in the blood and liver. The mechanisms leading to occult HBV infection remain poorly understood but include possible genetic mutations and deletions. Recently, it has been shown that HBV has CpG islands that are methylated, raising the possibility that epigenetic changes may also be important.
Occult hepatitis B virus (HBV) infection is defined by the presence of HBV DNA in the serum or liver of individuals with test results negative for the hepatitis B surface antigen (HBsAg) [1] . Occult HBV infection has been detected in diverse groups of individuals, including those with cryptogenic advanced liver fibrosis [2] , parenteral blood exposure [3, 4] , and chronic hepatitis C infection [1, 5] . The clinical consequences of occult HBV infection are incompletely defined, but current data potentially link occult HBV infection to liver enzyme flares [6] , advanced fibrosis [2] , and hepatocellular carcinoma [7] .
The mechanisms leading to occult HBV are poorly understood but may include: (1) mutations in the surface protein that cause decreased immune recognition [8] , (2) deletions in the pre-S1 region that impair HBV packaging [9, 10] , (3) various mutations in HBV-regulatory regions that lead to decreased HBsAg expression [10, 11] , and (4) mutations affecting posttranslation protein production [12] . In addition to these potential mechanisms, the HBV genome can be methylated [13] , and histone acetylation can regulate viral gene expression [14] , suggesting a potential role for epigenetic regulation of HBV. Finally, HBV DNA can undergo massive hyperediting from APOBEC3G [15, 16] , 1 member of a family of deaminating proteins that are part of the innate immune system's defense against viral infection. These findings raise the possibility that extensive editing of the HBV genome by deaminating proteins could contribute to the development of occult HBV.
Taken together, these observations suggest that multiple mechanisms may be relevant to occult HBV in- fection. Thus, we undertook a comprehensive analysis of the genetic and epigenetic changes in occult HBV, investigating the potential role of mutations and deletions, APOBEC3G hyperediting, and HBV methylation.
MATERIALS AND METHODS

Samples
Five cases of occult HBV infection were studied, which represent 5 of 6 cases of occult HBV infection identified by us in published [6, 17] and unpublished tissue surveys of the prevalence of occult HBV infection. In the remaining case, the fulllength genome was not amplifiable. Viral integration was excluded for all tissues by Alu-HBV PCR [18] . All HBsAg testing was performed in the course of clinical care, and the results of serological testing for HBsAg were negative in 4 of 5 cases of occult HBV infection (table 1) . In the last case (affecting a referral patient), laboratory testing was not performed at our institution, and test results were not available; however, the clinical records indicated that the patient had test results that were negative for hepatitis, and histological examination of the nonneoplastic liver confirmed the absence of chronic hepatitis and fibrosis. Because both tumor and nontumor tissues were available for the cases of occult HBV infection, both tumor and nontumor tissues were randomly selected for controls, as follows: for analysis of the complete genome, 2 cases of nonoccult HBV infection with paired healthy and tumor tissue samples (total, 4 samples); for hyperediting and methylation studies, 4 cases of nonoccult HBV infection with paired healthy and tumor tissue samples (total, 8 samples). All control tissue samples were from HBsAg-positive, HBeAg-negative individuals.
Baseline HBV sequences. Baseline sequences of nonoccult HBV were identified in the National Center for Biotechnology Information database and were assembled for comparison with the occult HBV genomes. The sequences were complete HBV sequences from serum, and separate sets were assembled for genotype A ( ), genotype C ( ), and genotype D n p 63 n p 40 ( ). Sequences were numbered from the EcoRI digestion n p 29 site.
HBV DNA Extraction and HBV DNA PCR Assays
HBV DNA was extracted from frozen liver tissues, and PCR was performed as reported elsewhere (primers are provided in table 2) [19] . All occult and nonoccult HBV samples were amplified under identical conditions. The following PCR assays were performed: (1) real-time PCR for the S gene, (2) seminested S gene PCR, and (3) nested PCR for covalently closed circular form DNA (cccDNA) [20] . Real-time PCR was performed with the SmartCycler system (Cepheid) with use of the Faststart SYBRgreen master mix (Roche), as described elsewhere [19] , and results were normalized to an external standard curve derived from serial dilutions of cloned HBV. PCR cycling conditions are available on request. For each sample, the bcatenin gene was amplified as a positive control for quality of DNA extraction with use of methods described elsewhere [21] . HBV genotypes were determined by directly sequencing the seminested surface gene product (672 base-pair fragment).
HBV DNA Amplification and Cloning for Whole-Genome Analyses
The full-length HBV genome was amplified using polymerase with proofreading capabilities (Takara) in 2 fragments, with use of primers described elsewhere [22] for fragment A (nucleotides 1686 to 660; 2195 base-pair fragment) and redesigned primers for fragment B (nucleotides 260-1786; 1526 base-pair frag- 
Detection of Hyperedited Sequences
Differential DNA denaturing PCR (3D PCR) can identify viral nucleic acids with increased GrA or CrT transitions. This method relies on the observation that either of these transitions leads to a lower melting temperature for the mutated nucleic acid and so employs a lower denaturing temperature during PCR cycling [23] . 3D PCR was performed under conditions similar to those described by Suspéne et. al. [23] (primers are shown in table 2). The region of the X gene was chosen for analysis because others have shown it to be hyperedited [15] , and it does not show evidence of significant mutation pressure induced by the adaptive immune system, in contrast with other regions of HBV [24] .
Detection of Methylated Sequences
HBV genotype A has 3 CpG islands [13] , but islands 1 and 2 were studied because of their proximity to regulatory regions of the HBV genome [13] . DNA bisulfite treatment was performed using standard procedures with the EpiTect Bisulfite Kit (Qiagen). At least 5 clones were sequenced for each island.
RESULTS
The cases of occult HBV infection occurred in 2 men and 3 women, and both tumor and nontumor tissue samples were available for analysis (table 1) . Three individuals had cirrhosis due to chronic hepatitis C virus infection (2 patients) or alcohol consumption (1 patient). For the remaining 2 patients, there was no evidence of advanced fibrosis, and tissues were obtained at the time of surgery for intrahepatic cholangiocarcinoma (for both patients). Four cases of occult HBV infection were due to genotype A virus, and 1 was due to genotype D virus. As expected, HBV DNA copy numbers were low (table 3) . HBV cccDNA was detectable in the tissues of 4 of 5 patients with occult cases and 6 of 8 patients with nonoccult cases (table 3).
Confirmation that Occult HBV Template Numbers Are High Enough for Cloning
The subsequent studies all made use of cloning. Because the amount of template DNA in cases of occult HBV infection can be very low, the initial PCR could potentially involve so few copies that sequencing data from cloning could represent resampling of only a few original templates. To investigate this, we performed the S gene PCR at a 1:10 dilution, and a PCR product was still evident (table 3) . The number of templates Table 4 . Base-pair changes in key regulatory regions of the hepatitis B virus (HBV) genome.
HBV region a
Results, by specimen from which HBV strain was isolated O1 O2 O3 O4
Enhancer I (nt 1060-1260) A1135C (10), T1151C (1), G1153A (2), and T1207W (1) A1076G (1), C1084T (1), C1129T (1), and T1167C (8) A1074T (9), A1077G (9), A1135C (1), C1146T (1), T1167A (1), and G1215A (9) G1192A (1), C1212T (1), and W1250C (10)
Enhancer II (nt 1635-1714) A1654G (1) and A1689G (1) G1692A ( (1), and C1810T (9) T1605A (1), C1615T (1), G1692A (1), T1767C (1), G1779A (1), A1805G (1), and A1818G (1) T1533C (1), T1580C (1), G1606A (1), T1716C (1), G1733A (3), G1734A (3), G1763A (3), and C1810T (3) G1572A (1), A1711G (9), and A1819G (1) X promoter (nt 1230-1374) R1320C (9) and A1374G (1) T1349C (1) and V1368T (8) T1283C (9), T1311C (1), and A1314G (1) W1250C (10) S1 promoter (nt 2710-2800) T2711C (10), T2717C (10), A2727C (10), and A2760G (1) T2711C (1), T2736C (1), M2745T (1), T2762C (1), T2764C (1), and T2766C (1) T2711C (3), D2714C (4), G2715A (7), T2717C (6), G2721A (7), A2727C (6), A2752C (1), T2765G (4), D2774C (1), and G2776T (1) A2736G (9) S2 promoter (nt 2960-3180) T2965G (10), C2975T (10), C2991T (10), C2994T (10), Y3021A (10), G3033A (1), and G3035A (10) C3011T (1), A3023G (1), C3054T (1), T3077C (1), T3082C (1), G3150A (1), and T3176C (1) T2965R (9), C2975T (7), C2991T (8), C2993T (4), C2994T (9), A3002G (1), A3012G (1), A3015G (1), C3022T (3), G3028A (4), G3035A (7), G3081A (1), and T3090C (1) T3013A (9) and C3092T (1)
NOTE. Data are base-pair change (no. of clones). Changes are in comparison with consensus sequences created from full-length serum sequences from National Center for Biotechnology Information. Changes affecting the majority of clones for any given case are shown in bold. NA, not applicable for genotypes C and/or D at these positions; nt, nucleotide position. C, control case of nonoccult HBV infection; N, nonneoplastic liver tissue; O, occult HBV infection; T, tumor.
in the PCRs that generated amplicons for cloning were calculated to have a range of 70-600 copies per reaction.
Whole-Genome Analysis
All occult clones had numerous base-pair changes, many of which were located in key regulatory regions of the HBV genome (table 4) . Interestingly, a gradation was evident, with O5 showing few changes in these key regions, with occult case 2 (O2) and O4 showing intermediate levels, and with occult case 1 (O1) and 3 (O3) showing the most changes, particularly in the S1 and S2 promoters. Other significant changes included a C2398T change in all clones of O1 that would lead to an amber stop codon in the HBV surface gene messenger RNA. Analysis of key regions of the predicted S protein (table 5) showed only occasional changes in a minority of clones for the "a" determinant in all cases except for O4, which had 1 predicted amino acid change that was present in all clones. A change in the cytotoxic T lymphocyte region were present in the majority of clones of O1, O3, and O4, although similar changes were present in strains isolated from control liver tissues. Rare clones with mutations in the start codons of the various HBV proteins were present: small s protein (O1, 1 clone; O3, 1 clone) and the X protein (O1, 1 clone). No changes were found in nucleotide position 458, which can interfere with HBV RNA splicing. Overall, changes at any given nucleotide position were limited to a minority of cases of occult HBV infection. The 1 exception (T667C), which was present in all genotype A strains from cases of occult HBV infection, is of unclear significance, because no amino acid changes are predicted for the S or P gene transcripts.
Further analysis of dominant changes in occult HBV strains showed that their numbers varied widely, with a range of 4-61 nucleotide positions (table 6). In the strains isolated from control nonoccult tissues, dominant changes had a range of (1), and G1763A (2) C1534 (2), A1617G (1), C1618A (1), T1628T (9), T1667G (1), C1673A (1), A1679C (9), G1717A (1), T1771C (1), and T1784C (1) T1598C, T1604G, G1611A, A1705G (1), and C1810T (4) T1566C, A1623G, A1793G (2), and C1810T (7)
(1), and G1356A (1) G1249C (9), T1250C (9), C1316T (1), and A1319C (1) A1234C (1), G1273A (1), C1316T (1), R1320C (10), C1321A (2), and G1327A (1) T1250G (1), A1278G (1), A1284G (1), C1316T (1), R1320C (10), and T1322A (1) C2743T (1) T2720C (1) 
a Regions of the HBV genome shown include those that are known to be relevant to HBV protein production or replication. b There were no base-pair changes in any sample for the G458A HBV region.
20-62 positions. In both occult and nonoccult strains, dominant changes were more common in strains isolated from tumor specimens than in strains isolated from control strains. To examine whether the locations of dominant changes differed between occult and nonoccult strains, the number of polymorphic or mutated nucleotide positions over 50-base-pair intervals were calculated. No overall signature emerged for the location of dominant changes in occult HBV sequences ( figure  1A ). Because no region of the HBV genome emerged as being targeted for dominant changes in occult HBV strains, compared with nonoccult HBV strains (figure 1A), further analysis was performed to study the locations of sites with any degree of polymorphism among occult HBV strains, with use of National Center for Biotechnology Information genome sequences for HBV isolated from the serum as controls. For this analysis, cases of genotype A HBV infection were the focus, because the majority of cases of occult HBV infection involved genotype A strains. The number of polymorphic or mutated nucleotide positions over 50-base-pair intervals were again calculated for occult HBV strains and serum controls (figure 1B). The overall locations of polymorphic or mutated sites was similar between occult HBV strains and control HBV strains, which provided no strong evidence of mutational hotspots unique to occult HBV. Base-pair changes in occult HBV isolates appear to be subtly enriched in a few areas (such as from nucleotide position ∼1800 to nucleotide position ∼1950). However, the significance is uncertain, given that isolates from cases of nonoccult HBV infection also showed more changes in these same regions (figure 1A) .
Additional analysis showed that the majority of dominant changes were transitions, with a transition-to-transversion ratio of 2:1 (table 7) . Adenosine was the most commonly affected nucleotide (3.1% of total adenosines), followed by thymidine (8) P29L (3), S34L (9), and N40S (9) P29L (1), S31N (1), W35L (2), N40S (10), S45A (10), and Q51R (1) I28M (1), W35R (1), W35L (1), N40S (9), N40G (1), S45A (10), and L49P (1) NOTE. Data are base-pair change (no. of clones). Changes affecting the majority of clones are shown in bold. There were no amino acid changes in any sample for the G145R or G265S HBV regions. aa, Amino acid; C, control case of nonoccult HBV infection; HBsAg, hepatitis B surface antigen; HBV, hepatitis B virus; N, nonneoplastic liver tissue; O, occult HBV infection; T, tumor. (2.6%), cytidine (2.2%), and guanosine (1.7%). As expected, polymorphic nucleotide positions in the nonoccult HBV sequences were commonly polymorphic in occult HBV (table 6) . Control genotype A liver tissues (C2N and C2T) showed an overall similar pattern, with a transition-to-transversion ratio of 2:8 and nucleotide substitutions of T (1.9%), A (1.7%), C (1.4%), and G (1.2%).
Large Deletions
Large deletions were present in 3 occult and 2 nonoccult HBV infection cases (table 8) . Most deletions were inframe and were located in the pre-S1 region. Insertions in the S gene promoter were also observed in 1 case of occult infection but not in controls. No major deletions in the core or the X gene were detected.
Hyperediting of HBV DNA
Hyperediting of the HBV genome was evident in 1 case of occult infection (O1) and in 2 control cases (C1T and C2T control tissues) (table 9) . However, the whole-length cloning data did not show evidence of hyperediting of individual sequences, suggesting that the number of hyperedited sequences was !10%.
Methylation and HBV
Methylation was present in both occult and nonoccult HBV infection cases (table 10) . The number of clones with methylation of island 1 was similar for occult and nonoccult HBV infection cases ( , by x 2 test). In contrast, cases of occult P p .876 infection were more likely to involve methylation on island 2 ( ,b yx 2 test). Differences in methylation density were P p .003 also observed, with island 1 more densely methylated in cases of nonoccult HBV infection and island 2 more densely methylated in cases of occult HBV infection ( and P p .002 P p , respectively, by x 2 test). Interestingly, 05, which was .000 densely methylated, showed no deletions and the fewest basepair changes in key regulatory regions of the 5 occult cases.
DISCUSSION
Occult HBV sequences can demonstrate numerous mutations and deletions, a robust finding seen in this study and in most published reports that have examined the complete occult HBV genome [10, 11, 22] . Mutations and deletions are commonly found in key regulatory regions, providing plausible mechanisms that could disrupt surface-gene expression and viral replication. Despite this, detailed analysis of key regulatory regions and structural proteins in this and other studies [11] has failed to reveal any strong candidate nucleotide mutations that are both shared by most occult HBV strains and are absent in nonoccult HBV strains. Although occult HBV can have numerous mutations or polymorphisms, the overall locations of these mutations or polymorphisms reflect the patterns of polymorphic sites seen in nonoccult HBV isolates from tissue and serum, and no unique hotspots of commonly shared mutations were evident. Furthermore, the overall type of mutations (transitions) and affected base pairs are similar in occult HBV strains and nonoccult strains isolated from liver tissues. Thus, data currently suggest that the types and locations of mutations do not readily distinguish occult HBV from nonoccult HBV at the level of an individual sequence, even if the entire genome is analyzed. It remains plausible that the large volume of changes or unrecognized combinations of changes may yet be found to be characteristic of occult HBV. This portion of the study should be interpreted within the context of several data limitations. Ideally, the sequence data from the occult HBV strains could have been compared with large numbers of sequences from nonoccult HBV strains isolated from liver tissues. However, whole-length HBV sequencing data that permit direct comparison of mutations between the genome sequences of occult and nonoccult strains isolated from liver tissues are scant. Interpretation of data is further complicated by the observation that genetic changes can be more common in isolates obtained from tumor tissue samples compared with isolates from paired healthy tissues from the same individual, as seen in this study. In addition, the differences in the geographical origin of patients could, in part, account for sequence variations. Deletions remain intuitively attractive as potential markers of occult HBV. However, data from this and other studies [11] show that deletions are absent from some occult HBV strains and, importantly, are not unique to occult HBV but can be found in isolates obtained from both serum samples and liver tissues of individuals with nonoccult HBV infections, including those with high viral loads [25] . Thus, the role for deletions in occult HBV remains unclear. Because one of the defining features of occult HBV infection is the lack of detectable HBsAg in serum, considerable interest has focused on mutations in the surface gene and its regulatory regions. Mutations that cluster in key immunodominant regions of the surface protein have been reported in some [8, 22] but not other [2, 4] studies. In the present study, the HBV strain in O1 had mutations that created stop codons and could be predicted to interfere with protein production. The HBV strain in O4 also had an amino acid change in the "a" determinant. No additional data were identified to suggest that changes in the surface gene coding regions played major roles in the remaining 3 cases of occult HBV infection. Change in amino acid position 145 of the surface gene is one of the most commonly reported changes that renders the HBsAg more difficult to detect with routine serological testing [26] . No mutations were detected at amino acid position 145 in occult cases. This change was detected in a small proportion of sequences in isolates obtained from control tissues (C2N and C2T) . However, serum HBsAg was detectable in this control case.
The enhancer I region plays a key role in HBV gene expression and showed an A1135C mutation in occult (O1) and control (C2N and C2T) cases. The majority of clones from the 4 remaining occult cases (O2-O5) had at least 1 predominant point mutation in the enhancer I region. In the enhancer II region, 1 occult case (O4) was associated with an A1711G mutation (located in the b box). The commonly reported core promoter mutants A1762T and G1764A were not detected. However, several other mutations in the core promoter region were found. Numerous point mutations in the S1 and S2 promoters and the precore region were seen; however, none were unique to the occult HBV cases.
At the epigenetic level, methylation was evident in both occult and nonoccult HBV sequences, but occult HBV sequences had a different methylation pattern than did nonoccult HBV sequences. These findings may be an explanation for some cases of occult HBV infection and warrant additional investigation.
A single unifying genetic change or pattern of changes has yet to be identified that will reliably separate occult from nonoccult HBV sequences. However, it remains plausible that ge- netic changes, although not unique to occult HBV, play a role through the large volume of their changes or by yet-unrecognized combinations. Certainly, the weight of the evidence indicates that many of the genetic changes in occult HBV are at some level deleterious, even if they fail to completely explain the occult HBV status. A potential model of the genetic changes in occult HBV should then include several nonexclusive observations to account for the available data: (1) escape of im- mune recognition by changes in the S protein, (2) disruption of key regulatory regions of the HBV genome, (3) modification of posttranslational mechanisms, and (4) methylation of the HBV genome. Additional factors, at this time unknown, may also be important in occult HBV. As discussed in a recent review article [5] , it may be that the genetic changes are but part of the occult HBV story, with the immune system perhaps playing an important role. This possibility is strengthened by observations that occult HBV infection can be detected in individuals after spontaneous HBsAg seroclearance, and, in these cases, occult HBV appears to represent leftover virus in the liver after HBsAg seroconversion [27] . In this scenario, the viral genetic changes may not be the cause of occult HBV infection but may instead be characteristic of less fit viral sequences that are not as quickly cleared from the liver by the immune system. Also of note, occult HBV infection in liver transplant recipients often follows an indolent course [28, 29] , suggesting that the virus, in many cases, retains significant genetic changes that constrain its replicative ability despite suppression of the immune system. In conclusion, the available data at this time best support a model in which multiple nonexclusive genetic and epigenetic changes characterize occult HBV DNA sequences. However, which of these factors are causal remains unclear.
